# Wockhardt Ltd (WOCKPHARMA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1892.9
Day Change: -1.46%
52W High: ₹1868.8
52W Low: ₹1086.7
Market Cap: ₹25,463 Cr

## Valuation
P/E: 119.25
P/B: 5.56
EPS: ₹13.14
Book Value: ₹281.63
Dividend Yield: 0%

## Returns
1Y Return: 46.44%

## Profitability
ROE: 4.01%
ROCE: 5.79%
Debt/Equity: 0.42
Revenue Growth: 26%
Profit Growth: 296.7%
EBITDA Margin: 18.68%
Operating Margin: 14.82%

## About
Wockhardt Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Wockhardt Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: 2026-06-08T18:00:31.419Z
Latest Price History Date: 2026-06-08
Technicals Updated: 2026-06-08T18:00:31.419Z
Quant Updated: 2026-06-08T18:00:31.419Z
Sentiment Updated: 2026-06-08T18:00:31.419Z
Financials Status: current
Financials Updated: 2026-05-18T08:31:40.361Z
Financials Last Attempt: 2026-05-18T08:31:40.361Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (Mar 2016)
Revenue: ₹4482 Cr
Operating Profit: ₹709 Cr (OPM 16%)
Net Profit: ₹413 Cr
Tax: ₹575 Cr

## Annual P&L History
Mar 2016: Rev ₹4482Cr | PAT ₹413Cr | OPM 16%
Mar 2017: Rev ₹4453Cr | PAT ₹252Cr | OPM 11%
Mar 2018: Rev ₹4015Cr | PAT ₹-226Cr | OPM 0%

## Balance Sheet (Mar 2016)
Total Assets: ₹6939 Cr
Total Liabilities: ₹6939 Cr
Borrowings: ₹2309 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Habil Fakhruddin Khorakiwala, Founder & Executive Chairman
- Murtaza Habil Khorakiwala, MD & Executive Director
- Huzaifa Habil Khorakiwala, Executive Director
- Deepak R. Madnani, Chief Financial Officer
- Sachin  Bhagwat, Chief Scientific Officer

---
Source: rupiya.io/stocks/wockpharma
Disclaimer: For research and education only. Not investment advice.